Hitting the Bullseye With Anti-BCMA Treatment: An In the Clinic Activity Evaluation (ID: i838-5) Survey

Question Title

* 2. How many patients with multiple myeloma do you manage per week? 

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. After participating in this activity, how confident are you now in the management of patients with relapsed/refractory multiple myeloma (RRMM) in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity? 

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 6. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Increased ability to select anti-BCMA treatment for patients with RRMM

Increased familiarity with clinical trials of anti-BCMA agents

Increased familiarity with the adverse events associated with anti-BCMA therapies

Increased ability to manage adverse events associated with anti-BCMA therapies

Increased ability to implement multidisciplinary care strategies for patients receiving anti-BCMA therapy

Question Title

* 7. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc)	Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc) Strongly agree	Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc) Agree	Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc) Neutral	Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc) Disagree	Assess patients and select appropriate therapy based upon patient (comorbid conditions, proximity to treatment center, personal preferences) and disease characteristics (aggressiveness, stage, etc) Strongly disagree
Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects	Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects Strongly agree	Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects Agree	Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects Neutral	Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects Disagree	Incorporate multidisciplinary strategies to provide optimal care and management of treatment-related side effects Strongly disagree

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.

Ola Landgren, MD, PhD effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

Sagar Lonial, MD, FACP effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for multiple myeloma.

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with multiple myeloma do you manage per week?

Question Title

* 3. After participating in this activity, how confident are you now in the management of patients with relapsed/refractory multiple myeloma (RRMM) in your practice?

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

Question Title

* 6. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 7. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.After participating in today’s activity, I am now better able to:

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.Ola Landgren, MD, PhD effectively:

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.Sagar Lonial, MD, FACP effectively:

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.The content presented:

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for multiple myeloma.

* 2. How many patients with multiple myeloma do you manage per week? 

* 4. How committed are you to making changes in your practice based on your participation in this activity? 

* 8. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

* 9. Please rate your level of agreement by checking the appropriate rating.

Ola Landgren, MD, PhD effectively:

* 10. Please rate your level of agreement by checking the appropriate rating.

Sagar Lonial, MD, FACP effectively:

* 11. Please rate your level of agreement by checking the appropriate rating.

The content presented: